Beauty Farm Medical and Health Industry Inc. disclosed that it repurchased 13,500 ordinary shares on 27 April 2026 via on-market transactions on the Hong Kong Stock Exchange.

The shares were acquired at prices ranging from HK$21.12 to HK$21.50, translating into a volume-weighted average cost of HK$21.34 per share and a total outlay of approximately HK$0.29 million.

Following the transaction, the company’s treasury stock increased from 1.63 million to 1.64 million shares, while the number of issued shares (excluding treasury shares) decreased marginally to 249.95 million. The buy-back represents about 0.0054% of the company’s outstanding shares before the transaction.

The purchase was executed under the general mandate approved on 27 June 2025, which authorises Beauty Farm to repurchase up to 23.58 million shares. To date, 1.64 million shares—equivalent to 0.70% of the share count when the mandate was granted—have been bought back.

In line with Hong Kong listing rules, Beauty Farm is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, ending on 27 May 2026. The company confirmed that the repurchase complied with all applicable regulations and that no material changes have been made to the explanatory statement filed with the Exchange.